Spots Global Cancer Trial Database for cytomegaloviral infection
Every month we try and update this database with for cytomegaloviral infection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation | NCT05589844 | Cytomegaloviral... Hematopoietic a... | Allogeneic Hema... Biospecimen Col... CMV pp65 Peptid... | 18 Years - | Roswell Park Cancer Institute | |
| Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients | NCT05101213 | Adenovirus Infe... BK Virus Infect... Cytomegaloviral... Hematopoietic a... JC Virus Infect... Malignant Solid... Symptomatic COV... | Virus-specific ... | 18 Years - | M.D. Anderson Cancer Center | |
| A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation | NCT05589844 | Cytomegaloviral... Hematopoietic a... | Allogeneic Hema... Biospecimen Col... CMV pp65 Peptid... | 18 Years - | Roswell Park Cancer Institute | |
| Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant | NCT02506933 | Accelerated Pha... Acute Lymphobla... Acute Myeloid L... Chronic Lymphoc... Chronic Phase C... Cytomegaloviral... Hodgkin Lymphom... Lymphadenopathy Lymphoblastic L... Myelodysplastic... Myelofibrosis Myeloproliferat... Non-Hodgkin Lym... | Laboratory Biom... Multi-peptide C... Placebo | 18 Years - 75 Years | City of Hope Medical Center | |
| Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection | NCT02210078 | Cytomegaloviral... Hematopoietic a... Malignant Solid... | Allogeneic Cyto... | - | M.D. Anderson Cancer Center | |
| Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant | NCT02506933 | Accelerated Pha... Acute Lymphobla... Acute Myeloid L... Chronic Lymphoc... Chronic Phase C... Cytomegaloviral... Hodgkin Lymphom... Lymphadenopathy Lymphoblastic L... Myelodysplastic... Myelofibrosis Myeloproliferat... Non-Hodgkin Lym... | Laboratory Biom... Multi-peptide C... Placebo | 18 Years - 75 Years | City of Hope Medical Center | |
| Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients | NCT05101213 | Adenovirus Infe... BK Virus Infect... Cytomegaloviral... Hematopoietic a... JC Virus Infect... Malignant Solid... Symptomatic COV... | Virus-specific ... | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
